PublicationsPublications
Asian J Androl. 2008 Jan;10(1):54-9.
Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury.
Clin Oral Implants Res. 2008 May;19(5):522-9.
Sinus floor augmentation with recombinant human growth and differentiation factor-5 (rhGDF-5): a histological and histomorphometric study in the Goettingen miniature pig.
J Clin Periodontol. 2008 Nov;35(11):976-84.
Development of an injectable composite as a carrier for growth factor-enhanced periodontal regeneration.
J Sex Med. 2008 Aug;5(8):1866-75.
Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury.
Hum Mol Genet. 2008 May 1;17(9):1222-33.
